Circular RNAs in diseases
Circular RNAs in diseases is a research topic within Molecular Biology. Science Explorer counts 31k research works in it since 1961. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the biogenesis, regulation, and diverse functions of circular RNAs, with a particular emphasis on their roles as microRNA sponges, potential cancer biomarkers, and their involvement in various cellular functions. The papers also explore the translation of circular RNAs, their association with exosomes, and their implications in disease.
- Circular RNAs
- Biogenesis
- Regulation
- MicroRNA Sponges
- Cancer Biomarkers
- Exosome
- Translation
- Splicing
- Cellular Functions
- Disease
- Research works
- 31k fractional, since 1961
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -21% the tick is no change
- Largest producer
China
73% of the 10 largest, 2022-now
Which countries lead Circular RNAs in diseases research?
By volume, China and the United States publish the most (5.9k and 656 works in 2022-now).
By volume, 2022-now
- 1
China 5.9k works
- 2
United States 656 works
- 3
Iran 402 works
- 4
India 310 works
- 5
Italy 175 works
- 6
Egypt 134 works
- 7
Germany 115 works
- 8
South Korea 115 works
- 9
Russia 109 works
- 10
Japan 104 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Circular RNAs in diseases research?
By volume in 2022-now, Nanjing Medical University publishes the most Circular RNAs in diseases research, followed by Central South University and Sun Yat-sen University.
By volume, 2022-now
- 1
Nanjing Medical University
China 159 works
- 2
Central South University
China 138 works
- 3
Sun Yat-sen University
China 129 works
- 4
Shanghai Jiao Tong University
China 102 works
- 5
Harbin Medical University
China 91 works
- 6
Zhejiang University
China 88 works
- 7
Zhengzhou University
China 86 works
- 8
Soochow University
China 82 works
- 9
Nantong University
China 79 works
- 10
China Medical University
China 77 works
Who are the leading researchers in Circular RNAs in diseases?
The most-cited researchers publishing on Circular RNAs in diseases include Zhong Lin Wang, Guido Kroemer and Gad A. Getz.
- 1
Zhong Lin Wang
United States 491k citations
- 2
Guido Kroemer
France 386k citations
- 3
Gad A. Getz
United States 364k citations
- 4
Elaine R. Mardis
United States 346k citations
- 5
Hermann Brenner
Germany 343k citations
- 6
Jun Wang
China 340k citations
- 7
John P. A. Ioannidis
United States 317k citations
- 8
Gregory Y.H. Lip
United Kingdom 311k citations
- 9
Robert A. Weinberg
United States 301k citations
- 10
Richard A. Gibbs
United States 292k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Circular RNAs in diseases research done?
The largest centres of Circular RNAs in diseases research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Nantong and Hengyang.
Largest cities, 2022-now
Where it is the local speciality
- NantongCN · 74.2 works18×
- HengyangCN · 49.6 works16×
Location quotient: how much more of its research is in Circular RNAs in diseases than the world average.
Where is the best place to study Circular RNAs in diseases?
Among universities, judged by research, Sun Yat-sen University, Hunan University of Traditional Chinese Medicine and Central South University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Circular RNAs in diseases, country by countryIs Circular RNAs in diseases research growing?
Output in 2022-2025 was 21% lower than in 2018-2021, peaking in 2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Circular RNAs in diseases as a percentage of every work published that year, 0.037% in 2024.
Fractional works of Circular RNAs in diseases over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Circular RNAs in diseases. Posts are plain text and can be reported.